Log in

Relevant bibliographies by topics / Menstrual disorder

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Menstrual disorder'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Menstrual disorder.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Menstrual disorder"

1

Huong Nguyen, Thu. "Menstrual Cycle in Female Workers." Journal of Asian Multicultural Research for Medical and Health Science Study 1, no. 1 (August 14, 2020): 29–34. http://dx.doi.org/10.47616/jamrmhss.v1i1.21.

Full text

Abstract:

Menstrual disorders are abnormalities that occur in the menstrual cycle. There are various menstrual disorders that women can experience, ranging from too little or too much menstrual blood, painful menstruation, to depression before menstruation or premenstrual dysphoric disorder. Physical activity is divided into three levels, namely light, moderate and heavy physical activity. Physical activity of heavy intensity can cause physiological disorders of the menstrual cycle. presence of menstruation (amenorrhoea), thinning of the bones (osteoporosis), menstrual irregularities or intermenstrual bleeding, abnormal growth of the uterine wall, and infertility.

APA, Harvard, Vancouver, ISO, and other styles

2

Vale, Beatriz, Sara Brito, Lígia Paulos, and Pascoal Moleiro. "Menstruation disorders in adolescents with eating disorders – target body mass index percentiles for their resolution." Einstein (São Paulo) 12, no. 2 (June 2014): 175–80. http://dx.doi.org/10.1590/s1679-45082014ao2942.

Full text

Abstract:

Objective To analyse the progression of body mass index in eating disorders and to determine the percentile for establishment and resolution of the disease.Methods A retrospective descriptive cross-sectional study. Review of clinical files of adolescents with eating disorders.Results Of the 62 female adolescents studied with eating disorders, 51 presented with eating disorder not otherwise specified, 10 anorexia nervosa, and 1 bulimia nervosa. Twenty-one of these adolescents had menstrual disorders; in that, 14 secondary amenorrhea and 7 menstrual irregularities (6 eating disorder not otherwise specified, and 1 bulimia nervosa). In average, in anorectic adolescents, the initial body mass index was in 75thpercentile; secondary amenorrhea was established 1 month after onset of the disease; minimum weight was 76.6% of ideal body mass index (at 4th percentile) at 10.2 months of disease; and resolution of amenorrhea occurred at 24 months, with average weight recovery of 93.4% of the ideal. In eating disorder not otherwise specified with menstrual disorder (n=10), the mean initial body mass index was at 85thpercentile; minimal weight was in average 97.7% of the ideal value (minimum body mass index was in 52nd percentile) at 14.9 months of disease; body mass index stabilization occured at 1.6 year of disease; and mean body mass index was in 73rd percentile. Considering eating disorder not otherwise specified with secondary amenorrhea (n=4); secondary amenorrhea occurred at 4 months, with resolution at 12 months of disease (mean 65th percentile body mass index).Conclusion One-third of the eating disorder group had menstrual disorder − two-thirds presented with amenorrhea. This study indicated that for the resolution of their menstrual disturbance the body mass index percentiles to be achieved by female adolescents with eating disorders was 25-50 in anorexia nervosa, and 50-75, in eating disorder not otherwise specified.

APA, Harvard, Vancouver, ISO, and other styles

3

Kuzmina-Kavetskaya, N. A. "Effect of mud therapy on menstrual function." Kazan medical journal 29, no. 3 (November 19, 2021): 231–33. http://dx.doi.org/10.17816/kazmj80595.

Full text

Abstract:

The question of the influence of balneological treatment on menstrual function and the admissibility of using mud baths during the menstrual period has long attracted the attention of Russian doctors. So, back in 1826, Dr. Konrad noted good results in the treatment of menstrual disorders in the Caucasus. And even earlier, as can be seen from the announcement about Lipetsk, published under Peter I, menstruation disorder was considered an indication for spa treatment. Puparev (1847) and Brykov (1848) point to the beneficial effect of balneological treatment for menstrual disorders. In the journal of the Ministry of Internal Affairs for 1853, in an article about the Odessa estuaries, in the number of indications, menstruation disorder was indicated.

APA, Harvard, Vancouver, ISO, and other styles

4

Khatiwada, Saroj, Sharad Gautam, Rajendra KC, Shruti Singh, Shrijana Shrestha, Punam Jha, Nirmal Baral, and Madhab Lamsal. "Pattern of Thyroid Dysfunction in Women with Menstrual Disorders." Annals of Clinical Chemistry and Laboratory Medicine 2, no. 1 (May 3, 2016): 3–6. http://dx.doi.org/10.3126/acclm.v2i1.14195.

Full text

Abstract:

BACKGROUNDThyroid disorders are among the commonest endocrine disorders worldwide. Thyroid dysfunction can interfere in multiple metabolic and physiological processes including menstrual cycle. This study was conducted to find pattern of thyroid dysfunction among women with menstrual disorders.METHODSTwo hundred thirty three females with menstrual disorders were screened for thyroid dysfunction. Thyroid function was assessed by measuring serum free triiodothyronine (T3), free thyroxine (T4) and thyroid stimulating hormone (TSH) levels.RESULTSThe mean age of study patients was 25.7±6.8 years. The most common menstrual disorder observed was irregular cycle (72.5%, n=169) followed by amenorrhea (21.9%, n=51) and menorrhagia (5.6%, n=13). Most of the patients were in the age group 15-24 years (51.1%, n=119), followed by 25-34 years (36.1%, n=84) and 35-45 years (12.9%, n=30). Mean level of free T3 and T4 was 2.91±1.05 pg/ml, 1.42±0.57 ng/dl respectively. Median TSH was 2.0 mIU/L (IQR, 1.0-4.0). Thyroid dysfunction was seen in 25.8% (n=60) women. Most common thyroid dysfunction was subclinical hypothyroidism (14.2%, n=33) followed by subclinical hyperthyroidism (6.9%, n=16), overt hyperthyroidism (3%, n=7) and overt hypothyroidism (1.7%, n=4).CONCLUSIONSThe study finds thyroid dysfunction especially subclinical hypothyroidism to be common among women with menstrual disorders. Thus, it may be beneficial to screen menstrual disorder patients for thyroid function especially to rule out thyroid disorder as potential etiological agent for menstrual disturbance.

APA, Harvard, Vancouver, ISO, and other styles

5

Lee Barron, Mary. "Light Exposure, Melatonin Secretion, and Menstrual Cycle Parameters: An Integrative Review." Biological Research For Nursing 9, no. 1 (July 2007): 49–69. http://dx.doi.org/10.1177/1099800407303337.

Full text

Abstract:

Dysfunction in menstrual physiology has pronounced effects on quality of life, involving mood changes, body image, infertility, and pregnancy complications. Light exposure may affect menstrual cycles and symptoms through the influence of melatonin secretion. The purpose of this systematic review is to determine the current state of knowledge about the effects of light and melatonin secretion on menstrual phase and cycle alterations. A brief overview of the influence of melatonin on human physiology is included. There is evidence of a relationship between light exposure and melatonin secretion and irregular menstrual cycles, menstrual cycle symptoms, and disordered ovarian function. In women with a psychopathology such as bipolar disorder or an endocrinopathy such as polycystic ovary syndrome, there seems to be greater vulnerability to the influence of light—dark exposure. Research on the complex role of light—dark exposure in menstrual physiology has implications for treatment of menstrual-associated disorders.

APA, Harvard, Vancouver, ISO, and other styles

6

Kumari, Anupma, Renu Rohatgi, and Amrita Singh. "Evaluation of thyroid dysfunction in patients with menstrual disorders of reproductive age group: a prospective cross-sectional study." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 2 (January 28, 2021): 642. http://dx.doi.org/10.18203/2320-1770.ijrcog20210320.

Full text

Abstract:

Background: Thyroid disorders specifically the hypothyroidism has been associated with menstrual disturbances in women of reproductive age group. The objective of this study was to estimate the prevalence of thyroid dysfunction and its correlation with menstrual disorders in women of reproductive age group.Methods: A hospital based prospective analytical study was carried out in the department of Obstetrics and Gynaecology of Nalanda Medical College and Hospital, Patna from March 2017 to March 2018. 56 women of reproductive age group between 18 to 45 years presenting with menstrual disorders (like menorrhagia, oligo/hypomenorrhea, polymenorrhea, metrorrhagia, and amenorrhea) were recruited in this study. Thyroid function test was done in all patients. Statistical analysis done.Results: Maximum number of patients were seen in the age group of 31-40 years. Most common menstrual complain was menorrhagia (46.42%) followed by hypo/oligomenorrhoea (17.86%). In patients with menstrual disorders, 41.07 % had thyroid disorders in which subclinical hypothyroidism was prevalent in 17.86%, overt hypothyroidism in 12.5%, and overt hyperthyroidism in 5.35% of the women. Menorrhagia was the commonest menstrual disorder (52.94%) seen in hypothyroid patients followed by polymenorrhoea. A high degree positive correlation was observed between thyroid dysfunction and menstrual disorder (Pearson correlation coefficient, r=0.93).Conclusions: Our study concluded that thyroid dysfunction should be considered as an important etiological factor for menstrual irregularity. Thus, thyroid function tests should be performed in all patients with menstrual irregularities to avoid unnecessary interventions like curettage and hysterectomy.

APA, Harvard, Vancouver, ISO, and other styles

7

Pakniat, Hamideh, Ezzatalsadat Hajiseyedjavadi, Hananeh Mirgaloybayat, and Ali Emami. "Prevalence of Menstrual Disorders and its Relationship With Quality of Life in Female High School Students." Journal of Qazvin University of Medical Sciences 24, no. 4 (October 1, 2020): 346–55. http://dx.doi.org/10.32598/jqums.24.4.4.

Full text

Abstract:

Background: Menstrual disorders in female students in the early years after menarche affect their physical, emotional and social functions. Objective: This study aimed to investigate the prevalence of menstrual disorders among female high school students and its relationship with their Quality of Life. Methods: This cross-sectional study was conducted on 1000 high school girls in Qazvin, Iran during 2017-2018. Their menstrual disorders and quality of life were evaluated by a demographic checklist and KIDSCREEN questionnaire, respectively. Data were analyzed using independent t-test. Findings: The mean age of high school girls was 15.9±0.93 years. The most common disorder was Premenstrual Syndrome (PMS) with a prevalence of 60%. Their quality of life had a significant relationship with PMS, menorrhagia, metorrhagia, dysmenorrhea, spotting, hypermenorrhea (P<0.001), polymenorrhea (P=0.005), hypomnorrhea (P=0.002) and amenorrhea (P=0.025). The quality of life of girls with these disorders were poorer compared to the girls with no menstrual disorder. Conclusion: Menstrual disorders are highly prevalent among female students, and have a considerable impact on their quality of life. Since this impact has the potential to have longer-term consequences, more efforts are needed to address and treat menstrual disorders in female students.

APA, Harvard, Vancouver, ISO, and other styles

8

Ruszkowska, Hanna, Magdalena Lewicka, Magdalena Sulima, Grzegorz Bakalczuk, Anna Taracha, and Artur Wdowiak. "Characteristics of Menstrual Disorders." Pielegniarstwo XXI wieku / Nursing in the 21st Century 17, no. 2 (June 1, 2018): 27–31. http://dx.doi.org/10.2478/pielxxiw-2018-0012.

Full text

Abstract:

Abstract Introduction. The structure was based on the World Health Organisation classification. The article includes description of main causes, diagnostics and treatment of menstrual disorders. Menstrual disorder is an abnormal condition in woman’s menstrual cycle. There are disorders of ovulation, cycle length, blood flow and others. The article reviews hypogonadotropic hypogonadism, disorders of hypothalamic pituitary axis, ovarian insufficiency, congenital malformations, hyperprolactinaemia, genetic syndromes, pituitary gland tumours and unclassified disorders like premenstrual syndrome and dysmenorrhoea. Aim. Analysis of current literature with the focus on the systematisation of menstrual disorders. Conclusion. It is crucial for medical practitioners, who take care of a female patient, to have reliable knowledge of not only physiology, but also menstrual disorders. It will allow an early recognition of the symptoms, proper diagnosis and treatment in the optimal time.

APA, Harvard, Vancouver, ISO, and other styles

9

Beals, Katherine A., and Melinda M. Manore. "Disorders of the Female Athlete Triad among Collegiate Athletes." International Journal of Sport Nutrition and Exercise Metabolism 12, no. 3 (September 2002): 281–93. http://dx.doi.org/10.1123/ijsnem.12.3.281.

Full text

Abstract:

This study examined the prevalence of and relationship between the disorders of the female athlete triad in collegiate athletes participating in aesthetic, endurance, or team/anaerobic sports. Participants were 425 female collegiate athletes from 7 universities across the United States. Disordered eating, menstrual dysfunction, and musculoskeletal injuries were assessed by a health/medical, dieting and menstrual history questionnaire, the Eating Attitudes Test (EAT-26), and the Eating Disorder Inventory Body Dissatisfaction Subscale (EDI-BD). The percentage of athletes reporting a clinical diagnosis of anorexia and bulimia nervosa was 3.3% and 2.3%, respectively; mean (±SD) EAT and EDI-BD scores were 10.6 ± 9.6 and 9.8 ± 7.6, respectively. The percentage of athletes with scores indicating “at-risk” behavior for an eating disorder were 15.2% using the EAT-26 and 32.4% using the EDI-BD. A similar percentage of athletes in aesthetic, endurance, and team/anaerobic sports reported a clinical diagnosis of anorexia or bulimia. However, athletes in aesthetic sports scored higher on the EAT-26 (13.5 ± 10.9) than athletes in endurance (10.0 ± 9.3) or team/anaerobic sports (9.9 ± 9.0, p < .02); and more athletes in aesthetic versus endurance or team/anaerobic sports scored above the EAT-26 cut-off score of 20 (p < .01). Menstrual irregularity was reported by 31% of the athletes not using oral contraceptives, and there were no group differences in the prevalence of self-reported menstrual irregularity. Muscle and bone injuries sustained during the collegiate career were reported by 65.9% and 34.3% of athletes, respectively, and more athletes in aesthetic versus endurance and team/anaerobic sports reported muscle (p = .005) and/or bone injuries (p < .001). Athletes “at risk” for eating disorders more frequently reported menstrual irregularity (p = .004) and sustained more bone injuries (p = .003) during their collegiate career. These data indicate that while the prevalence of clinical eating disorders is low in female collegiate athletes, many are “at risk” for an eating disorder, which places them at increased risk for menstrual irregularity and bone injuries.

APA, Harvard, Vancouver, ISO, and other styles

10

Ahmad Kamal, Azlan, Zarizi Ab Rahman, and Heldora Thomas. "The Impact of Menstrual Disorder Towards Female University Students." Athens Journal of Health and Medical Sciences 8, no. 2 (March 2, 2021): 119–34. http://dx.doi.org/10.30958/ajhms.8-2-3.

Full text

Abstract:

The purpose of this study is to study whether the menstrual disorder have impact on quality of life among female students which focus on physical and health education students from semester 1 until semester 8 in Uitm Puncak Alam, Selangor. The study was conducted to clarify the types of menstrual disorder among female students. The study also was aimed to identify the symptoms of menstrual disorder experience among female students before and during their menstruation and to determine the effect of menstrual disorder among female students towards their quality of life. Data from 74 respondents were used for the statistical analysis. The data were collected by using non purposive sampling. Questionnaires were used to obtain data for this study and the data for this study were analysed by using Microsoft Excel Software. Results showed that, menstrual disorder give impacts towards female quality of life. Future research should emphasize on other scope of study and more research about menstrual disorder may help organization to increase their performance and knowledge about female and their menstruation. Keywords: menstrual disorder, female students and effects, quality of life

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Menstrual disorder"

1

Wood, David. "Menstrual Disorder of the Adolescent." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/etsu-works/7678.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Parker, Melissa, and n/a. "The MDOT Study: Prevalence of Menstrual Disorder of Teenagers; exploring typical menstruation, menstrual pain (dysmenorrhoea), symptoms, PMS and endometriosis." University of Canberra. Health Sciences, 2006. http://erl.canberra.edu.au./public/adt-AUC20070813.161519.

Full text

Abstract:

There are few data available about the menstrual patterns of Australian teenagers and the prevalence of menstrual disorder in this age group. Aims To establish the typical experience of menstruation in a sample of 16-18 year old women attending ACT Secondary Colleges of Education. To determine the number of teenagers experiencing menstrual disorder that could require further investigation and management. Method The MDOT questionnaire was used to survey participants about their usual pattern of menstruation, signs and symptoms experienced with menses and how menstruation affected various aspects of their lives including school attendance, completion of school work, relationships, social, sexual and physical activity. Data analysis included exploration of aggregated data, as well as individual scrutiny of each questionnaire to determine menstrual disturbance requiring follow up. Those participants whose questionnaire indicated a requirement for further investigation, and who consented to being contacted, were followed up through an MDOT Clinic. Results One thousand and fifty one (1,05 1) completed questionnaires - 98% response rate. The typical experience of menstruation in the MDOT sample includes: bleeding patterns within normal parameters for this age group; menstrual pain, 94%; cramping pain, 71 %; symptoms associated with menstruation, 98.4%; PMS symptoms, 96%; mood disturbance before or during periods, 73%; school absence related to menstruation, 26%; high menstrual interference on one or more life activity, 55.8%; asymptomatic menstruation, 1 %; True response to 'My periods seem pretty normal' 7 1.4%. Statistically significant associations were found between each and all of: menstrual pain, symptoms, interference on life activities and school absence. The prevalence of significant menstrual disturbance in the sample is approximately 25% where: 2 1 % experienced severe pain; 26% reported school absence; 33% had seen a GP about periods; 26.9% think there is something wrong with periods; 23.5% require follow up based on individual scrutiny of each questionnaire; 10- 14% require further investigation to rule out endometriosis. Referral and investigation of menstrual pain, symptoms, and diagnosis of menstrual pathology in the sample was low. Conclusion The MDOT questionnaire has helped to establish a clearer picture of typical menstruation in the population sample. Where 1% of girls reported having asymptomatic menstruation, the majority of teenagers in the study reported menstrual pain and symptoms that could be experienced as part of the dysmenorrhoeic syndrome of symptoms, PMS, or underlying pathology such as endometriosis. Due to the overlap in symptoms and a propensity to be dismissive of menstrual pain and symptoms, many girls are suffering menstrual morbidities that could be well managed with NSAIDs and the oral contraceptive pill (OCP) if non-pathological, or investigated further if a menstrual pathology is suspected. Considering these results the reported school absence rate of 26% is not surprising. Whilst this study does not cost the true impact of menstrual disturbance on schooling, the results of the MDOT questionnaire reflect significant physical and emotional impact on a considerable number of teenager's lives which could also have repercussions on education, schooling performance and other areas of their lives. Future research is planned to determine the MDOT questionnaire's validity for identifying pathological menstrual disorder so it can act as a screening tool to facilitate earlier detection. Replication of the MDOT study should be done in younger teenagers (from menarche) to determine menstrual disturbance in the younger age group.

APA, Harvard, Vancouver, ISO, and other styles

3

Wiklund, Liselotte. "Premenstrual Dysphoric Disorder : A Review of Neural and Cognitive Changes in Women with PMDD." Thesis, Högskolan i Skövde, Institutionen för biovetenskap, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-14302.

Full text

Abstract:

Around 3-8% of all women in reproductive age suffer from premenstrual dysphoric disorder (PMDD) which disenables them to live an ordinary life during the luteal phase (premenstrual phase) of the menstrual cycle. Throughout the premenstrual phase these women experience emotional, cognitive and physiological changes. Hitherto, the etiology of this disorder is unknown. Some consider the source of this state as non-biological, claiming that PMDD is a social construction imbedded in gender roles, that suggests that women should not show aggressive behavior or depressive mood unless it is during the premenstrual stage. Contradictory, research made in cognitive neuroscience claim that the origin is biological. It is assumed that the increased symptoms in women with PMDD is a result from dysfunctional sensitivity for the progesterone metabolite allopregnanolone that has a receptor in the GABAA system, hence, producing an anxious effect from high levels of allopregnanolone instead of the expected sedative, soothing effects. Research suggest that structural and functional changes occur in brain areas such as the hippocampus, parahippocampus, amygdala, cerebellum as well as in brainderived neurotrophic factor which is important for brain plasticity, growth and survival of neurons. Cognitive behaviors such as anticipation for negative stimuli, working memory and lack of cognitive control also seem to be affected by PMDD. Nonetheless, the evidence is inconsistent, the area of research face multiple issues in regards to study designs, hence making generalization at this point difficult. In sum, this essay reviews recent studies conducted in neuroscience of cognitive changes in women with PMDD, with focus on functional, structural and behavioral changes between the phases of the cycle.

APA, Harvard, Vancouver, ISO, and other styles

4

Kolbäck, Erika, and Annelie Bodin. "Ett liv med Premenstruellt dysforiskt syndrom : - en intervjustudie." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-253663.

Full text

Abstract:

Bakgrund: PMDS är en relativt okänd diagnos. Det är en progression av Premenstruellt syndrom (PMS) men allvarligare och är ibland invalidiserande för den som lider utav det. Prevalensen av PMDS är cirka fem procent av alla fertila kvinnor. Syfte: Syftet var att undersöka hur kvinnor med diagnosen PMDS upplevde hur det är att leva med diagnosen, vilken behandling de provat samt bemötandet som de fått i kontakt med vården. Metod: För att kunna besvara syftet så valdes en kvalitativ studie i form av intervjuer. Detta för att få en utökad förståelse kring PMDS och vad sjukdomen innebär. Intervjuerna var semistrukturerade och sju kvinnor inkluderades i studien. Inklusionskriterierna för denna studie var kvinnor med diagnosen PMDS som har varit i kontakt med sjukvården och blivit diagnostiserade med sjukdomen. Intervjuerna analyserades med hjälp av innehållsanalys enligt Graneheim och Lundman (2004). Resultat: PMDS tycks fortfarande vara en relativt okänd diagnos inom sjukvården och en del av informanterna var inte nöjda med vården de mottagit medan andra haft tur och hittat rätt väg på en gång. Det är en svår diagnos att leva med som inkräktar på såväl vardagsliv som arbetsliv och alla mänskliga relationer. Informanterna anser att en utökad förståelse och hjälp från vården skulle underlätta deras leverne. Slutsats: Mer kunskap krävs inom både vården och för samhället i stort då detta är en allvarlig diagnos som behöver upptäckas i tid så dessa kvinnor kan få rätt hjälp. Det är livsavgörande att kvinnor med diagnosen PMDS får de verktyg de behöver för att kunna leva ett fullvärdigt liv.
Background: PMDD is a relatively unknown diagnosis. There is a progression of Premenstrual Syndrome (PMS), but serious and sometimes debilitating for the sufferer out of it. The prevalence of PMDD is about five percent of all women of childbearing potential. Purpose: The purpose of this study was to examine how women diagnosed with PMDD experienced how it is to live with the diagnosis, the treatment they have tried, and the response they got in contact with health services. Method: A qualitative survey based on interviews was made in order to comprehend the diagnosis PMDS and its symptoms. Seven women participated in semi-structured interviews. The terms and conditions in this survey included women diagnosed with PMDS by and in contact with the health care system. The interviews were analyzed in accordance to Graneheim and Lundman’s content analysis. Results: The result indicated that PMDS is a relatively unknown condition within the health care system. Some of the informants were not pleased with the treatment given. Others received efficient treatment straight away. PMDS is burdensome to live with and it affects working life as well as social relations in common life. Conclusion: Acquaintance, both within the health care system and the society as a whole, is crucial for women diagnosed with PMDS. PMDS is a serious diagnosis which has to be discovered early in order to give these women efficient treatment. It is essential that women diagnosed with PMDS get efficient tools to handle their diagnosis in order to live vital lives.

APA, Harvard, Vancouver, ISO, and other styles

5

Timby, Erika. "Allopregnanolone effects in women : clinical studies in relation to the menstrual cycle, premenstrual dysphoric disorder and oral contraceptive use." Doctoral thesis, Umeå universitet, Obstetrik och gynekologi, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-50058.

Full text

Abstract:

Background: Premenstrual dysphoric disorder (PMDD) affects 3–8% of women in fertile ages. Combined oral contraceptives (OCs) are widely used and some users experience adverse mood effects. The cyclicity of PMDD symptoms coincides with increased endogenous levels of allopregnanolone after ovulation. Allopregnanolone enhances the effect of γ-aminobutyric acid (GABA) on the GABAA receptor, the principal inhibitory transmitter system in the brain. The sensitivity to other GABAA receptor agonists than allopregnanolone (i.e. benzodiazepines, alcohol and the 5 β epimer to allopregnanolone, pregnanolone) has been reported to depend on menstrual cycle phase and/or PMDD diagnosis. Isoallopregnanolone, the 3 β epimer to allopregnanolone, has previously been used to verify specific allopregnanolone GABAA receptor effects. Saccadic eye velocity (SEV) is a sensitive and objective measurement of GABAA receptor function. Aims: To study the pharmacological effects, and any effect on gonadotropin release, of intravenous allopregnanolone in healthy women. A second aim was to explore whether allopregnanolone sensitivity differs over the menstrual cycle or during OC use in healthy women, and thirdly in PMDD patients. Methods: Ten women were challenged with a cumulative dose of intravenous allopregnanolone in the follicular phase of the menstrual cycle. The effect on FSH and LH was compared to women exposed to isoallopregnanolone. A single dose of allopregnanolone was administered once in the follicular phase and once in the luteal phase in another ten healthy women and in ten PMDD patients, and additionally in ten women using OCs. Repeated measurements of SEV, subjectively rated sedation and serum concentrations after allopregnanolone injections were performed in all studies. Results: Allopregnanolone dose-dependently reduced SEV and increased subjectively rated sedation. Healthy women had a decreased SEV response in the luteal phase compared to the follicular phase. By contrast, PMDD patients had a decreased SEV response and subjectively rated sedation response to allopregnanolone in the follicular phase compared to the luteal phase. There was no difference in the SEV response to allopregnanolone between women using oral contraceptives and healthy naturally cycling women. Allopregnanolone decreased serum levels of FSH and LH whereas isoallopregnanolone did not affect FSH and LH levels. Conclusion: Intravenous allopregnanolone was safely given and produced a sedative response in terms of SEV and subjectively rated sedation in women. The sensitivity to allopregnanolone was associated with menstrual cycle phase, but in the opposite direction in healthy women compared to PMDD patients. The results suggest mechanisms of physiological tolerance to allopregnanolone across the menstrual cycle in healthy women and support that PMDD patients have a disturbed GABAA receptor function. In addition, one of our studies suggests that allopregnanolone might be involved in the mechanism behind hypothalamic amenorrhea.

APA, Harvard, Vancouver, ISO, and other styles

6

Henz, Aline. "Diagnóstico da síndrome pré-menstrual : comparação de dois instrumentos - registro diário da intensidade dos problemas (DRSP) e instrumento de rastreamento de sintomas pré-menstruais (PSST)." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/139773.

Full text

Abstract:

Introdução: O diagnóstico da Síndrome Pré-menstrual (SPM) é um desafio. O uso de questionários estruturados está bem estabelecido, e a ferramenta mais aceita é o DRSP, um questionário prospectivo auto preenchido por ao menos dois meses. O PSST é um questionário retrospectivo de autoaplicação, preenchido em um único momento. Objetivo: comparar estes dois instrumentos (PSST e DRSP) para o diagnóstico da SPM. Método: Um estudo transversal com 127 mulheres entre 20 a 45 anos com queixas de SPM. As mulheres foram avaliadas quanto ao peso, altura, Índice de Massa Corporal (IMC). Após exclusão de casos de depressão através do Prime-MD, as pacientes completaram o PSST e foram orientadas a preencherem o DRSP durante dois meses. A concordância entre os dois questionários foi avaliado pelo cálculo de Kappa (k) e valores do coeficiente PABAK. Resultados: Do total de mulheres que atenderam ao chamado, 282 (74%) preencheram os critérios de elegibilidade e responderam o PSST. Entre estas 282 mulheres, somente 127 (45%) completaram o questionário diário (DRSP) por dois ciclos. O percentual das mulheres com diagnóstico de SPM através do DRSP foi de 74,8%, e pelo PSST foi 41,7%. O percentual das mulheres com diagnóstico de TDPM pelo DRSP foi de 3,9%, e pelo PSST foi de 34,6%. Assim, verificou-se uma maior prevalência de SPM com o DRSP do que com o PSST. De outra parte a TDPM foi mais dignosticada pelo PSST do que com o DRSP. O número de pacientes consideradas “normais” foi semelhante com os dois instrumentos. Na avaliação entre os dois instrumentos verificou-se não haver nenhuma concordância (Kappa = 0,12) nos resultados do diagnóstico de SPM e TDPM (Coeficiente Pabak resultou = 0,39). Para a trigem de SPM/TDPM o PSST tem uma sensibilidade de 79% e especificidade de 33,3%. Conclusão: O PSST deve ser considerado como uma ferramenta de triagem diagnóstica. Conclui-se que os casos SPM/TDPM do PSST devem ser sempre melhor avaliados pelo DRSP.
Background: The diagnosis of Premenstrual Syndrome (PMS) is a challenge. The use of structured questionnaires is well established and the most accepted is the DRSP, a prospectively self-administered questionnaire that needs two months at least to be completed. The PSST is a retrospective self-scale questionnaire, filled at a single time. Aim: To compare these two instruments (PSST and DRSP) to diagnosis PMS. Methods: A cross-sectional study with 127 women between 20 and 45 years with PMS complaints. The women were evaluated about weight, high, Body Mass Index (BMI). After the exclusion of depression by the Prime-MD Questionnaire, the PSST was completed and the women were oriented to complete the DRSP for two months. The agreement between the two questionnaires was assessed by calculating the Kappa (k) and PABAK values. Results: 282 (74% of all the women) women met eligibility criteria and answered the PSST. Only 127 (45% of the 282 women) completed the daily questionnaire (DRSP) for two cycles. The percentual of women with PMS diagnosis by the DRSP was 74.8%, and by PSST was 41.7%. The percentual of women with PMDD diagnosis by the DRSP was 3.9%, and by the PSST was 34.6%. The number of patients considered “normal” (with the symptoms above the necessary for the diagnostic the PMS) was similar with both questionnaires. We found no agreement between the two instruments (Kappa = 0.12) in the diagnosis of PMS and PMDD (Pabak coefficient keep this result = 0.39). For screening PMS/PMDD the PSST has a sensitivity of 79% and a specificity 33.3%. Conclusion: The PSST should be considered as diagnostic screening tool. We concluded that positive PMD/PMDD cases of PSST should be ever better evaluated by DRSP.

APA, Harvard, Vancouver, ISO, and other styles

7

Accortt, Eynav Elgavish. "FRONTAL ALPHA ELECTROENCEPHALOGRAPHY (EEG) ASYMMETRY AS A RISK FACTOR FOR PRE-MENSTRUAL DYSPHORIC DISORDER (PMDD); A PSYCHOPHYSIOLOGICAL AND FAMILY HISTORY APPROACH." Diss., The University of Arizona, 2009. http://hdl.handle.net/10150/193864.

Full text

Abstract:

Premenstrual dysphoric disorder (PMDD) is a severe dysphoric form of premenstrual syndrome (PMS) that is included as a diagnosis for further study in the DSM-IV (APA, 2000). A primary aim of the present study was to characterize the co-occurrence of PMDD and major depression, in a sample that spans the entire range of depressive severity. The range included non-depressed controls, women meeting criteria for dysthymia, and women meeting criteria for current Major Depressive Disorder (MDD). Co-occurrence of MDD and PMDD were only statistically significant when considering Lifetime MDD. Resting frontal electroencephalographic (EEG) asymmetry has been hypothesized to tap a diathesis toward depression or other emotion-related psychopathology. Another primary aim was to assess Frontal EEG asymmetry in college women who meet criteria for Pre-Menstrual Dysphoric Disorder (n = 25) and 25 matched controls. Participants were assessed four times in a two week period. Women reporting low premenstrual dysphoric symptomatology exhibited greater relative left frontal activity at rest than did women high in premenstrual dysphoric symptomatology. These results are consistent with a diathesis-stress model for premenstrual dysphoric symptomatology. A secondary aim was to assess whether individuals with PMDD or menstrual related mood variability, but no current diagnosis of depression, have an increased family history of depression. Promising evidence of a relationship between family history of MDD and a likelihood of PMDD was discovered. A trend was found for Spectrum PMDD women: a higher rate of Family History of MDD (36%) than non PMDD women (19.6%). Ideally, resting frontal electroencephalographic (EEG) asymmetry could help us learn more about the etiology of depression and hormonal-related depression specifically, and test whether they may share etiological factors.

APA, Harvard, Vancouver, ISO, and other styles

8

Beddig, Theresa [Verfasser], and Christine [Akademischer Betreuer] Kühner. "Ambulatory Assessment of Psychological and Psychoendocrinological Characteristics across the Menstrual Cycle in Women with Premenstrual Dysphoric Disorder / Theresa Beddig ; Betreuer: Christine Kühner." Heidelberg : Universitätsbibliothek Heidelberg, 2020. http://d-nb.info/1218785233/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Eisenlohr-Moul, Tory A. "Expression of Borderline Personality Disorder Symptoms across the Ovulatory Cycle: A Multilevel Investigation." UKnowledge, 2013. http://uknowledge.uky.edu/psychology_etds/24.

Full text

Abstract:

Borderline Personality Disorder (BPD) is a disabling condition characterized by chronic emotion dysregulation and behavioral impulsivity. Prospective studies that test proposed mechanisms of within-person change in BPD hold the key to improving symptom predictability and control in this disorder. A small body of evidence suggests that fluctuations in estradiol such as those occurring naturally at ovulation during the monthly female reproductive cycle may increase symptoms in women with BPD (DeSoto et al., 2003). Furthermore, there is preliminary evidence that both self-esteem and feelings of social rejection are highest at ovulation, when estradiol peaks (Durante and Hill, 2009; Eisenlohr-Moul et al., under review). Such feelings have been reliably linked to increases in BPD-related behavior in all individuals (e.g., Twenge et al., 2002). The purpose of this dissertation was to test a cyclical vulnerability model for women with BPD in which ovulatory estradiol shifts are associated with reductions in felt social acceptance, which in turn are associated with increased BPD symptom expression. 40 women, sampled to achieve a flat distribution of BPD symptoms, completed 28 daily diaries online, as well as four 1-hour weekly visits to the laboratory to complete longer assessments and provide saliva samples, which were assayed for estradiol. In addition, participants underwent the Structured Clinical Interview for the Diagnosis of BPD at the end of the study. Results of multilevel models revealed the opposite of the predicted effects of within-person changes in estradiol and their interaction with trait BPD. The data suggest a pattern in which women high in trait BPD show increases in felt acceptance and reductions in BPD symptom expression at higher levels of conception probability and higher-than-usual levels of estradiol. Women low in trait BPD show the opposite pattern in some cases. Several alternative moderators were tested, and results suggest that some risk factors for BPD (e.g., Neuroticism, Sexual Abuse) interact with high trait levels of estradiol to predict greater symptoms. Both average levels of estradiol and monthly fluctuations in estradiol may have relevance for women with BPD. It is recommended that future studies utilize clinical samples and additional physiological measures to further elucidate the mechanisms through which estradiol exerts clinically-relevant change.

APA, Harvard, Vancouver, ISO, and other styles

10

Dias, Rodrigo da Silva. "Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5142/tde-28052010-101220/.

Full text

Abstract:

O impacto da flutuação dos hormônios esteróides sobre o curso do Transtorno Afetivo Bipolar durante a vida reprodutiva das mulheres é pouco estudado. Encontramos ainda muitas lacunas no conhecimento quanto a sua apresentação clínica e as suas implicações na evolução do Transtorno Afetivo Bipolar, especialmente sua associação com a ciclagem rápida e o seu valor preditivo para recorrência. Métodos: Mulheres com Transtorno Afetivo Bipolar (tipos I, II ou sem outra especificação) participantes do Systematic Treatment Enhancement Program for Bipolar Disorder, com idade entre 16 e 40 anos, foram divididas em dois grupos: com e sem relato de exacerbação pré-menstrual do Transtorno Afetivo Bipolar na avaliação inicial do estudo. Estes grupos foram comparados em relação às características clínicas do Transtorno Afetivo Bipolar, de vida reprodutiva e tratamento na entrada do estudo. Longitudinalmente, foi comparado o tempo de recorrência entre as pacientes que iniciaram o estudo eutímicas utilizando análise de sobrevivência Kaplan Meier e a regressão de Cox. O número de episódios entre as pacientes que foram seguidas por um período de um ano também foi comparado. Resultados: Das 706 mulheres que completaram o questionário, 490 (69,4%) relataram exacerbação pré-menstrual. Na entrada do estudo, quando comparadas ao grupo sem exacerbação pré-menstrual, as mulheres com exacerbação pré-menstrual encontravam-se mais deprimidas, apresentavam mais comorbidades psiquiátricas, sintomas do humor com uso de contraceptivos hormonais, ciclos menstruais irregulares, e estavam recebendo menos tratamento farmacológico. Mulheres com exacerbação pré-menstrual também relataram mais episódios de humor durante o ano anterior e eram mais susceptíveis de apresentar ciclagem rápida neste mesmo período. Na avaliação prospectiva, entre as mulheres que iniciaram o estudo eutímicas (exacerbação pré-menstrual n = 66, sem exacerbação pré-menstrual n = 63), o grupo com exacerbação pré-menstrual teve um tempo de recaída mais rápido ao se incluir estados subsindrômicos associados a recaídas em mania, depressão ou estado misto. O tempo médio de recidiva de 50% da amostra foi de 4,5 meses para as mulheres com a exacerbação pré-menstrual, em comparação com 8,5 meses para as do grupo sem exacerbação pré-menstrual (p = 0,02). A exacerbação prémenstrual também foi um fator significativamente associado a maior gravidade dos sintomas depressivos e de elevação do humor entre as mulheres com um ano de seguimento. Conclusões: As mulheres com Transtorno Afetivo Bipolar que relataram exacerbação pré-menstrual apresentaram uma maior comorbidade psiquiátrica, maior número de episódios do humor no ano anterior e ciclagem rápida. A avaliação prospectiva mostrou uma taxa de recorrência maior, mais estados subsindrômicos e maior número de episódios, mas não ciclagem rápida, nas mulheres do grupo exacerbação pré-menstrual. Nossos resultados sugerem que a exacerbação pré-menstrual pode ser considerada um marcador clínico preditor de um fenótipo clínico mais complexo e associado a uma pior evolução da doença em mulheres em idade reprodutiva com Transtorno Afetivo Bipolar.
The impact of hormonal fluctuation during the menstrual cycle on the course of bipolar disorder in women is poorly studied. We also found many gaps in knowledge about its clinical presentation and its implications for the evolution of Bipolar Disorder, especially the association with rapid cycling and its predictive value for recurrence. Methods: Women with Bipolar Disorder (types I, II or Not Otherwise Specificated ) participants Systematic Treatment Enhancement Program for Bipolar Disorder, aged between 16 and 40, were divided into two groups: with and without reports of Premenstrual Exacerbation of Bipolar Disorder in the baseline assessment. These groups were compared to clinical features of BD, reproductive life and treatment at study entry. The time difference of recurrence between groups who were euthymic at the baseline assessment were done with survival analysis Kaplan Meier\'s survival curve and Cox regression models. The number of episodes between the patients who were followed for a period of one year was also compared. Results: Of 706 women who completed the questionnaire, 490 (69.4%) reported premenstrual exacerbation. At study entry, compared to those without premenstrual exacerbation, women with premenstrual exacerbation were more depressed, had more psychiatric comorbidities, mood symptoms with the use of hormonal contraceptives, irregular menstrual cycles, and were receiving less drug treatment. Women with premenstrual exacerbation also reported more mood episodes during the previous year and were more likely to state rapid cycling in the same period. In a prospective evaluation among women who started the study in euthymic mood state (premenstrual exacerbation n = 66, without premenstrual exacerbation n = 63), the premenstrual exacerbation group had a smaller time to relapse when associated subsyndromal mood states to relapse in mania, depression or mixed state. The median time to relapse of 50% of the sample was 4.5 months for women with premenstrual exacerbation, compared with 8.5 months for the group without premenstrual exacerbation (p = 0,02). The premenstrual exacerbation was also a significantly positive factor for a greater severity of depressive symptoms and elevation of mood among women with one year of follow-up. Conclusions: Women with Bipolar Disorder who reported premenstrual exacerbation had a higher psychiatric comorbidity, greater number of episodes of mood in the previous year and rapid cycling. Prospective evaluation showed a higher rate of recurrence, more states and more subsyndromal episodes, but not rapid cycling among women in the premenstrual exacerbation. Our results suggest that premenstrual exacerbation can be considered a clinical marker predictor of a worse clinical phenotype and associated with a worst disease progression in women of reproductive with bipolar affective disorder

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Menstrual disorder"

1

Graham, Scambler, ed. Menstrual disorders. London: Tavistock/Routledge, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Berga, Sarah L., Andrea R. Genazzani, Frederick Naftolin, and Felice Petraglia, eds. Menstrual Cycle Related Disorders. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-14358-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Birke, Lynda. ?Por qué sufrir?: La regla y sus problemas. 2nd ed. Barcelona: laSal, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pirke, Karl Martin, Wolfgang Wuttke, and Ulrich Schweiger, eds. The Menstrual Cycle and Its Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-74631-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

1932-, Jewelewicz Raphael, and Warren Michelle P, eds. The menstrual cycle: Physiology, reproductive disorders, and infertility. New York: Oxford University Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Margaret, Rees, Hope Sally, and Ravnikar Veronica, eds. The abnormal menstrual cycle. London: Taylor & Francis, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Menstrual disorders and menopause: Biological, psychological, and cultural research. New York: Praeger, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Catherine, Gordon, ed. The menstrual cycle and adolescent health. Malden: Wiley-Blackwell, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

J, Dan Alice, Lewis Linda L. 1942-, and Society for Menstrual Cycle Research., eds. Menstrual health in women's lives. Urbana: University of Illinois Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pain-free periods: Natural ways to overcome menstrual problems. Rochester, Vt: Thorsons Publishers, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Menstrual disorder"

1

Proske, Uwe, David L. Morgan, Tamara Hew-Butler, Kevin G. Keenan, Roger M. Enoka, Sebastian Sixt, Josef Niebauer, et al. "Exercise-Associated Menstrual Disorder." In Encyclopedia of Exercise Medicine in Health and Disease, 324. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_4208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Beumont, P. J. V. "Menstrual Disorder and Other Hormonal Disturbances." In The Course of Eating Disorders, 257–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76634-3_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Forrest, Lauren F., Mara Smith, Joao Quevedo, and Benicio N. Frey. "Bipolar Disorder in Women: Menstrual Cycle, Perinatal Period, and Menopause Transition." In Women's Mental Health, 59–71. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-29081-8_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Choate, Laura H. "Treatment for Premenstrual Dysphoric Disorder: Navigating the Transition Through Depression and Menstrual Cycles." In Depression in Girls and Women Across the Lifespan, 69–99. New York, NY : Routledge, 2020.: Routledge, 2019. http://dx.doi.org/10.4324/9781315208046-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Skelton, Ann K. "Menstrual Disorders." In Family Medicine, 1369–80. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Felmar, Eugene. "Menstrual Disorders." In Family Medicine, 899–908. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Shazly, Sherif, and Shannon K. Laughlin-Tommaso. "Menstrual Disorders." In Gynecology, 45–104. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41128-2_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Johnson, Cynda Ann. "Menstrual Disorders." In Family Medicine, 813–20. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-4005-9_105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Stabile, Isabel, Tim Chard, and Gedis Grudzinskas. "Menstrual Disorders." In Clinical Obstetrics and Gynaecology, 141–48. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-85919-9_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Cyr, Peggy R., and Ann K. Skelton. "Menstrual Disorders." In Family Medicine, 874–81. New York, NY: Springer New York, 2003. http://dx.doi.org/10.1007/978-0-387-21744-4_103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Menstrual disorder"

1

Annarahayu, Lutfi, Yulia Lanti Retno Dewi, and Rita Benya Adriyani. "Meta-Analysis the Effect of Obesity in Menstrual Cycle Disorder." In The 8th International Conference on Public Health 2021. Masters Program in Public Health, Universitas Sebelas Maret, 2021. http://dx.doi.org/10.26911/ab.maternal.icph.08.2021.14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Anggaraeni, Widya, Kurnia Indriyanti, Linda Presti Fibriana, Nanik Nur Rosyidah, and Siti Muthoharoh. "The Association between Menstrual Disorder and Psychological Disorder in Pre-Menopause Women in Sidoarjo, East Java." In Mid International Conference on Public Health 2018. Masters Programme in Public Health, Universitas Sebelas Maret, 2018. http://dx.doi.org/10.26911/mid.icph.2018.03.23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Joyce, Kayla, Kara Thompson, Phillip Tibbo, Kimberley Good, Elizabeth O'Leary, Tara Perrot, Amanda Hudson, and Sherry Stewart. "The Impact of Depressed Mood and Coping Motives in those with Pre-Menstrual Dysphoric Disorder on Cannabis Use Quantity across the Menstrual Cycle." In 2020 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2021. http://dx.doi.org/10.26828/cannabis.2021.01.000.40.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

"Challenges of Thromboprophylaxis In Pregnancy: A 12 Months Audit and A Review of The Literature." In 4th International Conference on Biological & Health Sciences (CIC-BIOHS’2022). Cihan University, 2022. http://dx.doi.org/10.24086/biohs2022/paper.809.

Full text

Abstract:

The presentation is going to comprise of two parts: The first part will be about the role of the nurse in management of women and girls with inherited bleeding Disorder (IBD) in a comprehensive care centre. The role of the nurse within the multidisciplinary team is to provide educational and emotional support to the women and the facilitate and coordinate person-centred care. This will be followed by presentation of an audit that was carried out on antenatal thromboprophylaxis in a single centre. Over the recent decades, there is increasing focus on women with inherited bleeding disorders (WBD) which has brought more patients into Haemophilia Treatment Centres (HTC) around the globe. These women require input of a multidisciplinary team to improve outcomes in their gynaecological and obstetric care. Nurses play a pivotal role in patient and family education and in the coordination of the multidisciplinary team. Carriers of Haemophilia and women with IBD experience heavy menstrual bleeding, bleeding from dentistry, surgery, injury or childbirth. Symptoms are treated leading to full and active lives. The nurse is often the point of contact for women who are pregnant, to organise and schedule attendance at a multidisciplinary clinic. The nurse is able to offer regular monitoring of the outcome of interventions in an ongoing relationship with the woman.The number of WBD in HTC has increased and the nurse should play an active role in outreach and education in the developing world where the numbers of identified WBD falls further below the expected numbers based on prevalence.

APA, Harvard, Vancouver, ISO, and other styles

5

Stewart, Sherry, Kayla Joyce, Phillip Tibbo, Nacera Hanzal, and Kimberley Good. "PMS Affective Symptoms Indirectly Linked to Cannabis Use Frequency and Problems via Cannabis Coping Motives." In 2020 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2021. http://dx.doi.org/10.26828/cannabis.2021.01.000.34.

Full text

Abstract:

Background: Women with PMS have higher rates of substance use disorders but underlying mechanisms remain poorly understood. Research on the links of PMS to problematic substance use has largely omitted consideration of cannabis use. Design/Method: To fill these gaps, 87 cannabis using women (mean age = 28.9 years) completed a cross-sectional survey involving self-reports on their PMS symptoms on the Pre-Menstrual Scale – Short Form (PMS-SF), their usual motives for cannabis use on the Marijuana Motives Measure (MMM), their frequency of cannabis use in the last 30 days on the Cannabis Timeline Followback (C-TLFB), and their level of cannabis use problems on the Cannabis Use Disorder Identification Test (CUDIT). Analyses/Results: A series of multiple regressions were performed, along with Sobel tests of indirect effects, to examine the potential mediational role of cannabis motives in explaining the expected links of PMS symptoms with cannabis use frequency and problems. Separate models were run with cannabis use frequency and problems as outcomes, and with PMS affective and physiological symptoms as predictors. In each case, both coping motives and social motives (as a control to determine specificity) were tested as simultaneous mediators. PMS Affective (but not Physiological) symptoms were indirectly positively related to both cannabis use frequency and problems through Coping (but not Social) motives for use (Sobel tests = 2.01 and 2.26, respectively, p’s < .05). Discussion: Findings suggest that it is the affective symptoms of PMS (e.g., depressed mood), rather than the physiological symptoms (e.g., bloating, pain), that drive more frequent and problematic cannabis use in women. Moreover, the mechanism to explain this link appears to be coping (but not social) motives for cannabis use. Thus, those women with greater levels of PMS affective symptoms appear to use cannabis more frequently and problematically than other women by way of their greater use of cannabis to cope with negative mood.

APA, Harvard, Vancouver, ISO, and other styles

6

Dawes, J., D. Drummond, and N. Goodfield. "URINARY FIBRINOPEPTIDE A IN A HEALTHY POPULATION AND IN PATIENTS WITH PERIPHERAL VASCULAR DISEASE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643049.

Full text

Abstract:

Urinary fibrinopeptide A (FpA) concentrations may be a useful clinical marker of the activation of coagulation. They are not susceptible to false positives resulting from ex vivo activation, and sampling is noninvasive.Individual urine voidings were collected from cohorts of 30 healthy subjects in each age decade from birth to 70 years, and a further 24 between 70 and 100 years. Below the age of 70 the urinary FpA concentration was 1.72 ± 0.76 ng/ml, and there was no effect of age or sex. Within this population, 4% of samples contained FpA concentrations above the upper limit of normal (mean + 2.5 SD); intensive investigation of one case failed to reveal any renal or coagulative disorder, though the urinary FpA levels remained high (8.4 − 14.2 ng/ml). Above 70 years old, 29% of urinary FpA concentrations exceeded the upper limit of normal established on a younger population. Thus, urinary FpA does increase with advanced age, but this may well result from occult diseaseSampling of every urine voiding over 48h in 3 healthy individuals established that there is no diurnal pattern either in urinary FpA concentration or in rate of FpA excretion. Urinary FpA was unaffected by the phase of the menstrual cycle. Urine samples from patients with peripheral vascular disease were assayed, and 24% contained elevated concentrations of FpA. Urinary FpA is probably a valuable marker of low grade activation of coagulation, particularly in chronic conditions where the assay of plasma samples is frequently uninformative

APA, Harvard, Vancouver, ISO, and other styles

7

Tiwari, Mani, and Balakrishnan Menon. "Menstrual Disorders in Non-genital Tuberculosis – an Ignored Entity." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.1561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Pliekhova, Olesia. "FEATURES OF MENSTRUAL FUNCTION DISORDERS IN WOMEN OF REPRODUCTIVE AGE." In IMPATTO DELL'INNOVAZIONE SULLA SCIENZA: ASPETTI FONDAMENTALI E APPLICATI, chair I. Tuchkina. European Scientific Platform, 2020. http://dx.doi.org/10.36074/26.06.2020.v1.34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mahfoudh, Aouatef, Raja Ammar, Asma Kheder, Noura Bel Haj, Amira Omrane, and Taoufik Khalfallah. "P-65 Menstrual disorders in hairdressers: a cross-sectional study." In 28th International Symposium on Epidemiology in Occupational Health (EPICOH 2021). BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/oem-2021-epi.184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kirschbaum, Elisabeth M., Katharina Fischer, Jan C. Wuestenfeld, and Bernd Wolfarth. "238 Prevalence of menstrual disorders among German female elite athletes." In IOC World Conference on Prevention of Injury & Illness in Sport 2021. BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine, 2021. http://dx.doi.org/10.1136/bjsports-2021-ioc.220.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!